HER2 Gene Mutation Recruiting Phase 1 / 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0081068 (HER2 Gene Mutation)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05991518IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant TumorsTreatment